Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial

Detalles Bibliográficos
Autores principales: Niyomnaitham, Suvimol, Toh, Zheng Quan, Licciardi, Paul Vincent, Wongprompitak, Patimaporn, Srisutthisamphan, Kanjana, Copeland, Katherine Kradangna, Chokephaibulkit, Kulkanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212727/
https://www.ncbi.nlm.nih.gov/pubmed/35728642
http://dx.doi.org/10.1016/j.jinf.2022.06.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212727/
https://www.ncbi.nlm.nih.gov/pubmed/35728642
http://dx.doi.org/10.1016/j.jinf.2022.06.014

Ejemplares similares